EyePoint (EYPT) FCF Margin Growth (5y) (2015 - 2026)
EyePoint (EYPT) FCF Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.14 Mn |
| Dec 31, 2025 | -1.11 Mn |
| Sep 30, 2025 | -615,321.00 |
| Jun 30, 2025 | -104,909.00 |
| Mar 31, 2025 | 105.00 |
| Dec 31, 2024 | -19,033.00 |
| Sep 30, 2024 | 19,699.00 |
| Jun 30, 2024 | 2,802.00 |
| Mar 31, 2024 | 40,041.00 |
| Dec 31, 2023 | 61,115.00 |
| Sep 30, 2023 | 97,185.00 |
| Jun 30, 2023 | 129,776.00 |
| Mar 31, 2023 | 28,697.00 |
| Dec 31, 2022 | -138,444.00 |
| Sep 30, 2022 | 142,359.00 |
| Jun 30, 2022 | 48,583.00 |
| Mar 31, 2022 | 55,422.00 |
| Dec 31, 2021 | -6,041.00 |
| Sep 30, 2021 | 225,411.00 |
| Jun 30, 2021 | 134,985.00 |